We found that elevated NEK8 expression in glioma is associated with various clinical and pathological parameters (WHO grade, histological type, IDH, EGFR, PIK3CA status and primary therapy outcome) and survival time. This evidence concerns the gene NEK8 and central nervous system cancer.